2025 is not just another year in pharma – it’s a turning point. The industry is riding a wave of scientific breakthroughs, regulatory agility and patient-centric innovation that’s reshaping the very fabric of modern medicine.
From AI-assisted drug discovery to next-gen biologics, the pace of progress has never been faster – and the stakes have never been higher.
This year’s standout launches aren’t just incremental upgrades. They’re paradigm shifts. We’re seeing the rise of oral biologics, non-opioid painkillers, and therapies that treat the root cause of disease rather than just the symptoms. In terms of drug dynamics, the focus is sharper, the science deeper and the ambition bolder.
Check out the rest of the feature here
